Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (OtherWXIBF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS) and Wuxi Biologics (Cayman) (WXIBF) with bullish sentiments.
Introducing TipRanks MCP for Agents
- Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
- Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.
Senseonics Holdings (SENS)
In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Senseonics Holdings. The company’s shares closed last Tuesday at $7.43.
According to TipRanks.com, Jennings is a 3-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Senseonics Holdings with a $16.67 average price target, implying a 131.5% upside from current levels. In a report issued on June 8, Lake Street also maintained a Buy rating on the stock with a $12.00 price target.
See today’s best-performing stocks on TipRanks >>
Wuxi Biologics (Cayman) (WXIBF)
In a report issued on June 8, Laurence Tam from Morgan Stanley maintained a Buy rating on Wuxi Biologics (Cayman), with a price target of HK$50.00. The company’s shares closed last Wednesday at $4.40.
Tam has an average return of
According to TipRanks.com, Tam is ranked #10068 out of 12293 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Wuxi Biologics (Cayman) with a $5.78 average price target.
Read More on SENS:
Disclaimer & DisclosureReport an Issue
- Senseonics Expands European Eversense CGM Operations via Asset Deals
- Sean Lee Reiterates Buy on Senseonics, Maintains $14 Price Target on Strong CGM Data and Pipeline Prospects
- Senseonics announces further data from study of Eversense 365
- 5 Healthcare Stocks Set to Join the Russell 3000
- Senseonics Shareholders Approve Doubling Authorized Common Stock
